Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1

Conditions

Leukemia, Myeloid, Acute 561Leukemia 282Precursor Cell Lymphoblastic Leukemia-Lymphoma 235Myelodysplastic Syndromes 110Congenital Abnormalities 86Leukemia, Monocytic, Acute 84Leukemia, Myelomonocytic, Acute 82Leukemia, Erythroblastic, Acute 75Leukemia, Megakaryoblastic, Acute 72Lymphoma 65Burkitt Lymphoma 62Recurrence 61Leukemia, Myelomonocytic, Chronic 43Leukemia, Biphenotypic, Acute 43Lymphoma, Non-Hodgkin 41Blast Crisis 37Anemia, Refractory, with Excess of Blasts 36Leukemia, Myelogenous, Chronic, BCR-ABL Positive 35Leukemia, Lymphocytic, Chronic, B-Cell 33Lymphoma, Large B-Cell, Diffuse 30Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 28Myeloproliferative Disorders 27Lymphoma, Follicular 27Lymphoma, Large-Cell, Immunoblastic 25Lymphoma, Mantle-Cell 24Leukemia, Myeloid, Chronic-Phase 23Leukemia, Eosinophilic, Acute 23Hodgkin Disease 23Lymphoma, B-Cell, Marginal Zone 22Leukemia, Basophilic, Acute 22

Interventions

trametinib 2fludarabine 2thymoglobulin 1omipalisib 1fludarabine phosphate 1Rituximab 1Melphalan 1Levetiracetam 1Injections 1Cytarabine 1Cyclophosphamide 1Busulfan 1Biopsy 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatosis 1 × Cytarabine × Other hematologic neoplasm × Clear all
NCT05849662 2026-04-15

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1/2 Recruiting
58 enrolled
CNSOther hematologic neoplasm

Neurofibromatosis 1, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡